title: COVit.295.W0.nativ.Feces.B
organism: Homo sapiens
attributes.tag: treatment
attributes.value: B
attributes.tag: ethnicity
attributes.value: caucasian
attributes.tag: organism
attributes.value: Homo sapiens
attributes.tag: collection date
attributes.value: 2021
attributes.tag: target gene
attributes.value: 16S rRNA
attributes.tag: sex
attributes.value: female
attributes.tag: weight (kg)
attributes.value: 71
attributes.tag: scientific_name
attributes.value: Homo sapiens
attributes.tag: common name
attributes.value: human
attributes.tag: target subfragment
attributes.value: V3-V4
attributes.tag: height (cm)
attributes.value: 158
attributes.tag: pcr primers
attributes.value: 319F (ACTCCTACGGGAGGCAGCAG) and 804R (GGACTACHVGGGTWTCTAAT)
attributes.tag: project name
attributes.value: Nicotinamide in a Prospective, Double-Blind, Randomized, Placebo-Controlled Trial for the Therapy of Signs and Symptoms of Acute Covid 195
attributes.tag: sequencing method
attributes.value: Illumina MiSeq
attributes.tag: age
attributes.value: 41
attributes.tag: geographic location (country and/or sea)
attributes.value: Germany
attributes.tag: timepoint
attributes.value: W0
attributes.tag: ENA-LAST-UPDATE
attributes.value: 2023-05-03